Erratum
After the publication of [1], the authors noticed that a reference had been omitted from the text and reference list.
In the introduction and conclusion sections, there are references to using IGF-1 in human neuronal models of Phelan-McDermid syndrome. The correct reference for this study is:
Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R, Sebastiano V, Krawisz A, Froehlich W, Bernstein JA, Hallmayer JF, Dolmetsch RE. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature. 2013 Nov 14;503(7475):267–71. doi: 10.1038/nature12618. Epub 2013 Oct 16. PubMed PMID: 24132240
Reference
Kolevzon A, Bush L, Wang AT, Halpern D, Frank Y, Grodberg D, et al. A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome. Mol Autism. 2014;5:54.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/2040-2392-5-54.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Kolevzon, A., Bush, L., Wang, A.T. et al. Erratum: A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome. Molecular Autism 6, 31 (2015). https://doi.org/10.1186/s13229-015-0025-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13229-015-0025-0